跳至主要内容
临床试验/NCT01534780
NCT01534780已完成不适用

A Controlled Randomized Study of Protack, Securestrap and Glubran Glue as Fixation Devices in Laparoscopic Ventral Herniotomy

Horsens Hospital1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
Pain

研究概览

简要总结

Clinical, controlled, randomized, prospective study. Ventral hernias between 2(1.5)cm and 7 cm, laparoscopic surgery with intraperitoneal onlay mesh.

Three randomization groups of 25 patients giving a total of 75 patients. Mesh is fixated with either Protack, Securestrap or Glubran II. Primary outcome: postoperative pain on the 2nd postoperative day. Secondary outcomes: pain, quality of life, recurrence and adhesions at 1, 6, 12, 24, 36, 48 and 60 months postoperative.

详细描述

see brief summary

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •ventral hernia 2(1,5) < dia > 7 cm
  • •danish speaking
  • •of sound mind
  • •bmi < 35
  • •ASA 3 or less, no contra indication against laparoscopy

排除标准

  • •other size hernias,
  • •no danish,
  • •bmi > 35

研究组 & 干预措施

fixation with Glubran

Experimental

surgery

干预措施: laparoscopic ventral herniotomy (Procedure)

fixation with Glubran

Experimental

surgery

干预措施: Glubran (Device)

fixation with Protack

Experimental

干预措施: laparoscopic ventral herniotomy (Procedure)

fixation with Protack

Experimental

干预措施: Protack (Device)

fixation with Securestrap

Experimental

干预措施: laparoscopic ventral herniotomy (Procedure)

fixation with Securestrap

Experimental

干预措施: Securestrap (Device)

结局指标

主要结局

Pain

时间窗: 1 measurement, 2nd postoperative day

Dolo Test (VAS)

次要结局

  • hernia recurrence(7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60)
  • quality of life(7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60)
  • Pain(7 measurements, day 1, 3 and 4 and postoperative month 1, 6, 12, 24)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hans Friis-Andersen

Principal Investigator

Horsens Hospital

研究点 (1)

Loading locations...

相似试验